These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18001351)

  • 1. Increased dental caries in people with neurofibromatosis 1.
    Tucker T; Birch P; Savoy DM; Friedman JM
    Clin Genet; 2007 Dec; 72(6):524-7. PubMed ID: 18001351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
    Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
    J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Syndromes 18. Von Recklinghausen's disease].
    Baart JA; van Hagen JM
    Ned Tijdschr Tandheelkd; 2000 Feb; 107(2):57-9. PubMed ID: 11385791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Café-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: hyperpigmentation of a different kind?
    De Schepper S; Boucneau J; Vander Haeghen Y; Messiaen L; Naeyaert JM; Lambert J
    Arch Dermatol Res; 2006 Apr; 297(10):439-49. PubMed ID: 16479403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and clinical considerations in six cases with neurofibromatosis type 1.
    Buteică E; Stoicescu I; Burada F; Stănoiu B
    Rom J Morphol Embryol; 2007; 48(3):243-8. PubMed ID: 17914490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency associated with number of neurofibromas in neurofibromatosis 1.
    Lammert M; Friedman JM; Roth HJ; Friedrich RE; Kluwe L; Atkins D; Schooler T; Mautner VF
    J Med Genet; 2006 Oct; 43(10):810-3. PubMed ID: 16571643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of intrafamilial phenotypic variation in neurofibromatosis 1 (NF1).
    Szudek J; Joe H; Friedman JM
    Genet Epidemiol; 2002 Aug; 23(2):150-64. PubMed ID: 12214308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype.
    Pasmant E; Sabbagh A; Hanna N; Masliah-Planchon J; Jolly E; Goussard P; Ballerini P; Cartault F; Barbarot S; Landman-Parker J; Soufir N; Parfait B; Vidaud M; Wolkenstein P; Vidaud D; France RN
    J Med Genet; 2009 Jul; 46(7):425-30. PubMed ID: 19366998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.
    Faravelli F; Upadhyaya M; Osborn M; Huson SM; Hayward R; Winter R
    J Med Genet; 1999 Dec; 36(12):893-6. PubMed ID: 10593996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
    Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
    Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases.
    Wolkenstein P; Rodriguez D; Ferkal S; Gravier H; Buret V; Algans N; Simeoni MC; Bastuji-Garin S
    Br J Dermatol; 2009 Apr; 160(4):844-8. PubMed ID: 19067713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological study of neurofibromatosis type 1: an experience in Nigeria.
    Odebode TO; Afolayan EA; Adigun IA; Daramola OO
    Int J Dermatol; 2005 Feb; 44(2):116-20. PubMed ID: 15689208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological complications involving the central nervous system in neurofibromatosis type 1.
    Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
    Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pheochromocytoma associated with neurofibromatosis 1: a report of two cases].
    Sano F; Fujikawa N; Hirai K; Ueki T; Kitami K
    Hinyokika Kiyo; 2005 Dec; 51(12):793-5. PubMed ID: 16440725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of clinical features in neurofibromatosis 1 (NF1).
    Szudek J; Birch P; Riccardi VM; Evans DG; Friedman JM
    Genet Epidemiol; 2000 Dec; 19(4):429-39. PubMed ID: 11108651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically aggressive central giant cell granulomas in two patients with neurofibromatosis 1.
    Edwards PC; Fantasia JE; Saini T; Rosenberg TJ; Sachs SA; Ruggiero S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Dec; 102(6):765-72. PubMed ID: 17138179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Managing children with neurofibromatosis type 1: what should we look for?].
    Martins CL; Monteiro JP; Farias A; Fernandes R; Fonseca MJ
    Acta Med Port; 2007; 20(5):393-400. PubMed ID: 18282435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical study of type 1 neurofibromatosis in north west England.
    McGaughran JM; Harris DI; Donnai D; Teare D; MacLeod R; Westerbeek R; Kingston H; Super M; Harris R; Evans DG
    J Med Genet; 1999 Mar; 36(3):197-203. PubMed ID: 10204844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.